↓ Skip to main content

Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas

Overview of attention for article published in Investigational New Drugs, August 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas
Published in
Investigational New Drugs, August 2017
DOI 10.1007/s10637-017-0503-7
Pubmed ID
Authors

Franciele Cristina Kipper, Andrew Oliveira Silva, André Luis Marc, Gláucia Confortin, Augusto Valadão Junqueira, Eliseu Paglioli Neto, Guido Lenz

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 14%
Student > Ph. D. Student 6 14%
Researcher 6 14%
Student > Bachelor 6 14%
Student > Master 3 7%
Other 3 7%
Unknown 14 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 18%
Medicine and Dentistry 7 16%
Pharmacology, Toxicology and Pharmaceutical Science 6 14%
Chemistry 3 7%
Neuroscience 1 2%
Other 1 2%
Unknown 18 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#7,562,114
of 25,947,988 outputs
Outputs from Investigational New Drugs
#325
of 1,268 outputs
Outputs of similar age
#108,798
of 328,138 outputs
Outputs of similar age from Investigational New Drugs
#6
of 18 outputs
Altmetric has tracked 25,947,988 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,268 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.